Michael John Dunn Net Worth & Insider Trades
Michael John Dunn - Director, Acer Therapeutics Inc
What is Michael John Dunn's Net Worth?
The current estimated net worth of Acer Therapeutics Inc's Director, Michael John Dunn, is estimated to be about $10.25M . Michael John Dunn owns about 27,380 units of Acer Therapeutics Inc common stock. In the last 6 years at Acer Therapeutics Inc, Michael John Dunn has sold an estimated value of $0 worth.
What is Michael John Dunn's Past Insider Trading?
Michael John Dunn's largest purchase order was 21,428 units , worth over $75K on July 28, 2020. In total, Michael John Dunn has made about 7 transactions over 6 years of their time at Acer Therapeutics Inc. Michael John Dunn usually trades in January, with the busiest year in 2020.
MICHAEL JOHN DUNN
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Michael John Dunn's' Mailing Address?
- Mailing address is C/o Vital Therapies, Inc. 15010 Avenue of Science, Suite 200 San Diego CA 92128 CA
Acer Therapeutics Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|
| Chris Schelling | 2020 | $436,000 | $239,800 | - | - | $675,800 |
| Chris Schelling | 2019 | $436,000 | - | $1,031,211 | - | $1,467,211 |
| Harry S. Palmin | 2020 | $382,400 | $152,960 | - | - | $535,360 |
| Harry S. Palmin | 2019 | $382,400 | - | $462,041 | - | $844,441 |
| Donald R. Joseph | 2020 | $350,200 | $140,080 | - | - | $490,280 |
| No matching records found | ||||||
Source: https://www.sec.gov/Archives/edgar/data/1069308/000119312521119320/d57953ddef14a.htm
What are Acer Therapeutics Inc's Past Insider Trades?
Acer Therapeutics Inc's most recent insider trade came on December 1, 2022 by Chris Schelling who bought 819,672 units worth $1M . In the last 5 years, insiders at Acer Therapeutics Inc have sold an estimated value of $10.31K and bought an estimated value of $11.3M worth of shares. Insider trading is most common in January, with the busiest year in 2019 and 2022. The most active traders at the company are Steve Aselage, Director, Michael John Dunn, Director, and Chris Schelling, President & CEO .
Acer Therapeutics Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||